Regenstreif Lori, Sadik Marina, Beaulieu Erin, Bodkin Claire, Kiefer Lori, Guenter Dale, Lee Patsy W P, Kouyoumdjian Fiona G
Department of Family Medicine, McMaster University, 100 Main Street West, 5th Floor, Hamilton, ON, L8P 1H6, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Health Justice. 2022 Mar 2;10(1):11. doi: 10.1186/s40352-022-00174-w.
People with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical barriers to buprenorphine/naloxone initiation in correctional facilities. Guided by the knowledge-to-action framework, this knowledge translation project focused on synthesizing knowledge and developing a tool for buprenorphine/naloxone initiation that was tailored to correctional facilities, including jails. This information and tool can be used to support buprenorphine/naloxone access for people in correctional facilities, in parallel with other efforts to address barriers to treatment initiation in correctional facilities.
患有阿片类药物使用障碍的人在惩教机构中所占比例过高，且有阿片类药物过量的高风险。尽管丁丙诺啡/纳洛酮是治疗阿片类药物使用障碍患者的一线治疗方法，但在惩教机构中启动丁丙诺啡/纳洛酮治疗往往存在制度、临床和后勤方面的障碍。在知识转化行动框架的指导下，这个知识转化项目专注于整合知识，并开发一种专门针对惩教机构（包括监狱）启动丁丙诺啡/纳洛酮治疗的工具。这些信息和工具可用于支持惩教机构中的人员获取丁丙诺啡/纳洛酮，同时开展其他努力以消除惩教机构中治疗启动的障碍。
